PAVmed Announces Closing of its Public Offering of Common Stock 02/25/2021 | 01:38pm EDT Send by mail : Message : NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced underwritten public offering (the “Offering”) of approximately 9.8 million shares of its common stock for gross proceeds of approximately $45 million, before deducting underwriting discounts and commissions and other offering expenses payable by PAVmed. Cantor Fitzgerald & Co. acted as sole bookrunner for the Offering. Lake Street Capital Markets LLC and Maxim Group LLC acted as financial advisors to the Company.